Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses

Donald P. Tashkin, Bradley E. Chipps, Frank J Trudo, James G. Zangrilli
Published 2014 in
The Journal of asthma : official journal of the…

Abstract

BACKGROUND The role of fixed airflow obstruction (FAO) in asthma is unclear. OBJECTIVE To assess the relationship between FAO and clinical features of asthma and the effect of FAO on treatment response. METHODS Post hoc descriptive analysis of data stratified by FAO category (screening post-albuterol FEV1/FVC <lower limit of normal [LLN] [FAO+] or ≥LLN… (More)

DOI: 10.3109/02770903.2014.895012

Assessment of Consistency of Fixed Airflow Obstruction Status during Budesonide/Formoterol Treatment and Its Effects on Treatment Outcomes in Patients with Asthma.

Donald P Tashkin, Gary E Moore, Frank Trudo, Michael DePietro, Bradley E Chipps
The journal of allergy and clinical immunology…
2016

Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses

Abstract

Topics

6 Figures and Tables

Cited By

Asthma-chronic obstructive pulmonary disease overlap syndrome: What we know and what we need to find out.

Assessment of Consistency of Fixed Airflow Obstruction Status during Budesonide/Formoterol Treatment and Its Effects on Treatment Outcomes in Patients with Asthma.

Targeted Therapy for Severe Asthma: Identifying the Right Patients

The asthma–COPD overlap syndrome: how is it defined and what are its clinical implications?

References

Spirometric reference values from a sample of the general U.S. population.

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.

Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.

Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program.

Effect of bronchoconstriction on airway remodeling in asthma.

Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.

Rapid nongenomic actions of inhaled corticosteroids on long-acting β(2)-agonist transport in the airway.

Reference values for lung function: past, present and future.

Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus.

Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease

Slides referencing similar topics

Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses

Abstract

Topics

6 Figures and Tables

Cited By

Asthma-chronic obstructive pulmonary disease overlap syndrome: What we know and what we need to find out.

Assessment of Consistency of Fixed Airflow Obstruction Status during Budesonide/Formoterol Treatment and Its Effects on Treatment Outcomes in Patients with Asthma.

Targeted Therapy for Severe Asthma: Identifying the Right Patients

The asthma–COPD overlap syndrome: how is it defined and what are its clinical implications?

References

Spirometric reference values from a sample of the general U.S. population.

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.

Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.

Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program.

Effect of bronchoconstriction on airway remodeling in asthma.

Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.

Rapid nongenomic actions of inhaled corticosteroids on long-acting β(2)-agonist transport in the airway.

Reference values for lung function: past, present and future.

Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus.

Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease

Similar Papers

Slides referencing similar topics